Michael E. Chernew

Michael E. Chernew, PhD

Leonard D. Schaeffer Professor of Health Care Policy, Department of Health Care Policy, Harvard Medical School; Director, Healthcare Markets and Regulation Lab, Harvard Medical School

Michael Chernew, PhD, is the Leonard D. Schaeffer Professor of Health Care Policy and the Director of the Healthcare Markets and Regulation (HMR) Lab in the Department of Health Care Policy at Harvard Medical School. Dr. Chernew’s research examines several areas related to improving the health care system including studies of novel benefit designs, Medicare Advantage, alternative payment models, low value care and the causes and consequences of rising health care spending.   

Dr. Chernew is currently serving as the Chair of Medicare Payment Advisory Commission (MedPAC) while previously serving as the Vice Chair from 2012-2014 and a Member from 2008-2012. In 2000, 2004 and 2010, he served on technical advisory panels for the Center for Medicare and Medicaid Services (CMS) that reviewed the assumptions used by Medicare actuaries to assess the financial status of Medicare trust funds.  He is a member of the Congressional Budget Office’s Panel of Health Advisors and Vice Chair of the Massachusetts Health Connector Board. Dr. Chernew is a member of the National Academy of Sciences, a research associate at the National Bureau of Economic Research and a senior Visiting Fellow at MITRE. He is currently a co-editor of the American Journal of Managed Care.

Dr. Chernew earned his undergraduate degree from the University of Pennsylvania and his PhD in economics from Stanford University. In 1998, he was awarded the John D. Thompson Prize for Young Investigators by the Association of University Programs in Public Health. In 1999, he received the Alice S. Hersh Young Investigator Award from the Association of Health Services Research.

The Effect of a Large Regional Health Plan's Value-Based Insurance Design Program on Statin Use.
Authors: Frank M, Fendrick AM, He Y, et al.
Medical Care
View full abstract on Pubmed
The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment.
Authors: Grabowski DC, Lakdawalla D, Goldman D, et al.
Health Affairs
View full abstract on Pubmed
Competitive Bidding in Medicare: Who Benefits from Competition?
Authors: Song Z, Landrum MB and Chernew ME
American Journal of Managed Care
View full abstract on Pubmed
Potential consequences of reforming Medicare into a competitive bidding system
Authors: Song Z, Cutler DM, Chernew ME
Journal of the American Medical Association
View full abstract on Pubmed
The ‘Alternative Quality Contract,’ Based on a Global Budget, Lowering Medical Spending and Improved Quality.
Authors: Song A, Safran DG, Landon BE, et al.
Health Affairs
View full abstract on Pubmed
Slowing Medicare Spending Growth: Reaching for Common Ground
Authors: Chernew ME, Frank RG and Parente ST
American Journal of Managed Care
View full abstract on Pubmed
Measuring health care costs of individuals with employer-sponsored health insurance in the U.S.: A comparison of survey and claims data.
Authors: Aizcorbe A, Liebman E, Pack S, et al.
Statistical Journal of the International Association for Official Statistics
View full abstract on Pubmed
Gaps in treatment, treatment resumption, and cost sharing.
Authors: Gibson TG, Fendrick AM, Gatwood J, et al.
American Journal of Pharmacy Benefits
View full abstract on Pubmed
Why Physicians Should Like Bundled Payment

Health Services Research
View full abstract on Pubmed
State-level impacts of Medicare Part D
Authors: Afendulis CC and Chernew ME
American Journal of Managed Care
View full abstract on Pubmed